Japan Approves Gilead’s Remdesivir to Treat Covid-19 Cases

(Bloomberg) -- Japan on Thursday approved the antiviral drug remdesivir for use against the novel coronavirus, three days after receiving an application from Gilead Sciences Inc., the company said ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.